# Amyris Historicrestructuring (Amyris Inc.)
> Amyris Inc. is a synthetic biology company that transitioned from consumer goods back to its core technology platform following a major corporate restructuring in 2023-2024. The term 'Historicrestructuring' refers to its Chapter 11 reorganization process where it divested several consumer brands to focus on R&D and business-to-business ingredient production.
- URL: https://optimly.ai/brand/amyris-historicrestructuring
- Slug: amyris-historicrestructuring
- BAI Score: 15/100
- Archetype: Phantom
- Category: Biotechnology
- Last Analyzed: April 10, 2026
## Also Referenced By
- Genomatica (Geno) (https://optimly.ai/brand/genomatica-geno)
## Buyer Intent Signals
Problems: Internal Finance Teams: Companies in distress may attempt to manage liquidity and creditor negotiations using internal finance teams and spreadsheets. | Management Consulting: Hiring traditional management consulting firms to provide strategic direction during a downturn without formal legal restructuring. | General Legal Counsel: Relying on generic legal counsel who do not specialize in Chapter 11 or insolvency.
Solutions: synthetic biology companies 2024 | sustainable ingredient manufacturing partners | Amyris current operations post-bankruptcy | who bought Amyris brands | Amyris bio-tech restructuring details